G
GENPACT LTD
GENPACT LTD historical holders
total: 7
Greenhaven Associates GENPACT LTD transactions over time
- Total transactions:
- 8
- New positions:
- 1
- Added:
- 3
- Reduced:
- 4
- Held since:
- 2023 Q4
- Held for:
- 10 quarters
- Latest activity:
- 2025 Q3
Edgar Wachenheim III has been an institutional investor in GENPACT LTD (G) since 2023 Q4. According to 2026 Q1 report, Edgar Wachenheim III holds 10,000 shares with a market value of roughly $372.50K representing 0.01% of their equity portfolio. The fund/company first acquired G in 2023 Q4, initially purchasing 302,805 shares. Since the initial investment, Greenhaven Associates has made 7 more transactions in this position.
Does Edgar Wachenheim III still hold G?
Yes, Edgar Wachenheim III continues to hold GENPACT LTD (G). According to their 2026 Q1 report, they maintain a position of 10,000 shares valued at approximately $372.50K, representing 0.01% of their equity portfolio.
When did Edgar Wachenheim III first invest in G?
Edgar Wachenheim III first invested in GENPACT LTD (G) in 2023 Q4 at the reported quarter-end price of $34.71 per share, acquiring 302,805 shares in their initial purchase.
What is Edgar Wachenheim III's average cost basis for G?
Based on historical transaction data, Edgar Wachenheim III's estimated cost basis for GENPACT LTD (G) is approximately $33.30 per share. This represents their average reported price* across all buy transactions.
Estimated cost basis*
- Weighted AVG buy price:
- $33.30
- Weighted AVG sell price:
- $49.59
G transactions history by Greenhaven Associates
8 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2025 Q3
|
0.01%
|
10,000
|
$41.89
|
$418,900
|
-9.24% (-1,018)
|
-0%
|
|
2025 Q2
|
0.01%
|
11,018
|
$44.01
|
$484,902
|
-92.49% (-135,660)
|
-0.09%
|
|
2025 Q1
|
0.12%
|
146,678
|
$50.38
|
$7,389,638
|
-88.08% (-1,083,660)
|
-0.81%
|
|
2024 Q4
|
0.78%
|
1,230,338
|
$42.95
|
$52,843,017
|
-1.08% (-13,475)
|
-0.01%
|
|
2024 Q3
|
0.57%
|
1,243,813
|
$39.21
|
$48,769,908
|
+0.24% (+3,038)
|
+0%
|
|
2024 Q2
|
0.52%
|
1,240,775
|
$32.19
|
$39,940,547
|
+14.08% (+153,140)
|
+0.06%
|
|
2024 Q1
|
0.33%
|
1,087,635
|
$32.95
|
$35,837,573
|
+259.19% (+784,830)
|
+0.24%
|
|
2023 Q4
|
0.11%
|
302,805
|
$34.71
|
$10,510,362
|
new
|
+0.11%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.